Description: S&P Global published a revised insurance capital model in November 2023. The revisions add considerable complexity to their insurance capital model and rely more on companies to fill out the detailed model inputs. In return, the new model allows for better risk differentiation and an overall better assessment of insurance company risk-adjusted capitalization. In this session we will review the new capital model in-depth, considering its implications for capital management and product development. By the end of the session, attendees should have a deeper understanding of the revised criteria of the S&P insurance capital model, including its most important risk drivers and how it relates to the AM Best 'BCAR' and the NAIC RBC capital models.

Description: Reunite with members and non-members in the China actuarial community to discuss recent topics and related issues in areas such as macroeconomic sharing, IFRS 17, product strategy, cross-border communication and discussion, and more. Advance your career through learning and networking opportunities, and share your experiences in the finance and insurance industries, as well as other fields related to actuarial science.

Description: Companies are looking to modernize their FP&A processes and functions to deliver actionable insights, particularly in light of regulatory changes such as IFRS 17, LDTI, and PBR. New key performance indicators (KPIs) are emerging and FP&A function needs to evolve and adapt to these new paradigms, being a key function in monitoring the company's financial performance. Discover perspectives from filers under different bases: statutory, GAAP and IFRS and come learn how to elevate and enrich data, models, processes, and technology amidst changes to regulatory reporting. You'll also cover key considerations for the optimal design and interaction model between Finance, Actuarial, and other departments.

Description: This session will provide a comprehensive overview of key aspects related to the GAAP/VM-21 valuation for RILA. We will discuss how VM-21 can reward companies for making conservative decisions and examine the key factors that drive different levels of VM-21 reserves and capital. We will also cover how ALM management for RILA differs from other annuities. The attendees will gain insights into practical considerations, challenges, and solutions in implementing RILA valuation.

Description: Learn about the innovations of life & health products and distribution in the Asia market.

Description: VM-22 will be finalized during 2025 with an optional phase-in period beginning 1/1/2026 and mandatory implementation by 1/1/2029. This session will discuss the regulation, including background, calculations, high-level results from the field test and other modeling, as well as key considerations and documentation for actuaries and companies as they prepare to transition their fixed annuities into a principle-based reserve framework. Attendees will gain a clearer understanding of the new VM chapter as well as some of the thinking behind the decisions made.

Description: The purpose of this session is to discuss hot topics pertaining to post-LDTI GAAP valuation for FIA and RILA products including FAS 133, market risk benefits, intangibles, and ceded GAAP. At the conclusion of this session, attendees will have a clear understanding of how the industry views GAAP approaches to indexed annuity products in a post-LDTI framework. In addition, attendees will learn about ongoing pain points in GAAP valuation for indexed annuities and areas of post-LDTI GAAP where the industry still has broad variation in methodology and application.

Description: The Society of Actuaries are once again offering a seminar that investigates all aspects of life insurance, annuity and long term care product tax compliance. Developed by the Taxation Section, participants will be brought up-to-date on recent Internal Revenue Service (IRS) guidance and learn about the newest tax issues related to product design and administration. Legal, IRS and product development experts will provide vital insights into the challenges of developing and administering products within the requirements of the Internal Revenue Code (IRC), and allow ample opportunities for networking, questions and information exchange.September 12The optional “boot camp” will provide an intense introduction to the basics of product taxation. The boot camp will include sessions focused on life insurance, annuities, and long-term care combination products. The basis of the boot camp will be the authoritative textbooks, “Life Insurance and Modified Endowments Under IRC Sections 7702 and 7702A” and the “Annuities Answer Book.” Book authors will conduct these optional programs. September 13–14The general sessions will feature product, tax, legal and compliance experts as well as Internal Revenue Service (IRS) representatives. Recent changes in the qualification requirements of insurance products and a host of product tax issues beyond Internal Revenue Code (IRC) section 7702 and 7702A will be emphasized.

Description: An overview of the NAIC Variable Annuity Reforms, including a discussion of perceived positives and challenges associated with the reforms.

Description: "Risk Management starts with identifying, quantifying, and then monitoring the key risks a company is exposed to. From a life company perspective the key risks are investment returns, expenses, and mortality. IFRS17 allows quantifying and measuring those key risks by building expectations, as in the initial recognition, and monitoring the actual outcomes achieved, as in subsequent measurement. Risk can be measured, monitored, and corrective action taken by allowing the experience to emerge and be compared to our initial estimates. Comparing initial vs. subsequent figures allows the company to identify whether it had a profitable quarter or not. For a profitable quarter, it makes sense to release profit from the CSM and RA accounts. For a non-profitable quarter, it makes sense to build up funds in the RA account from CSM funds so that no profit is released. In this case, the release from the CSM exactly matches the buildup of RA_release, as no funds are released to shareholders. Two examples of subsequent measurement scenarios will be given along with their initial Recognition figures: one exceeding IR figures and the other losing to IR figures. We will see how to manage risk by controlling the release of shareholder funds. Comparing actual vs. expected figures allows us to do this. We will also see how this affects the Embedded Value and Value of In-force business. Key Learning Outcomes: 1. Given the Initial recognition figures, compute profitability and required releases of the risk adjustment RA and CSM accounts. 2. Calculate subsequent measurement figures for SR_RA, SR_CSM, and Value of in-force business."